Self-injections Market - A Common Practice in Modern Medicine :Infinium Global Research

PUNE, India, March 17, 2020 /PRNewswire/ -- Infinium Global Research has recently published a global report on "Self-injections Market " (Type - Wearable Injectors, Needle-free Injectors, Pen Injectors, and Auto Injectors; Applications - Respiratory Therapy, Autoimmune Diseases, Orphan Diseases, and Hormonal Disorders; Usage - Reusable, and Disposable; Distribution Channel - Online Pharmacies, Private Clinics, and Hospital Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025" published by Infinium Global Research", the reported study estimated the market for self-injections will reach up to 135 billion in 2025, with a Compound Annual Growth Rate of 14.80%, in the forecast period (2019-2025).

https://mma.prnewswire.com/media/1097741/Infinium_Global_Research_Logo.jpg

Self-injections are a common practice in modern medicine. It is used to deliver drugs and vaccines. Several drugs and almost all injectable vaccines are delivered through self-injections. It is a safe and effective way to manage a variety of health conditions from diabetes to autoimmune disorders, such as rheumatoid arthritis and psoriatic disease.

Download Exclusive Sample Copy of Report: https://www.infiniumglobalresearch.com/reports/sample-request/4853

According to the International Diabetes Federation, the number of people with diabetes has risen from 108 million in 1980 to 463 million in 2019. The global diabetes prevalence in 2019 is estimated to be 9.3%, rising to 10.2% by 2030 and 10.9% by 2045. Diabetes prevalence has been rising more rapidly in middle and low-income countries. Furthermore, according to WHO, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Hence, the demand for self-injection devices that are used for treatment from such diseases is expected to increase with the increasing prevalence of chronic diseases.

Growing Number of Chronic Diseases is Set to Drive the Global Self-injections Industry

The growing number of chronic diseases is the primary growth factor for the self-injections market. Chronic diseases and conditions are on the rise across the world. An aging population and changes in societal behavior are fueling to a steady increase in these common and costly long-term health problems. According to the WHO, chronic disease prevalence is expected to rise by 57% by the year 2020. Furthermore, convenience if self-injections is boosting the growth of the market. On the other side, regulations on self-injections by FDA and Infection Control for Regulated Professionals are restraining the market growth.

Manufacturers Adopting Expansion, Acquisition & Partnership Strategies

The increasing trend towards self-treatment is driving a dynamic growth in the auto injector sector. In 2018 alone, end-user sales of drugs in auto injection systems increased by 31% worldwide. And of the six new drugs for self-injection approved by the US Food and Drug Administration (FDA) during that same year, two were approved in auto injector formats, with more being developed for future approval.

Recently, in October 2019, Haselmeier and Stevanato Group come into agreement to license the Axis-D pen-injector technology and intellectual property (IP) for Development, Manufacturing, and Supply of the Axis-D pen-injector in the Therapeutic Area of Diabetes Care. Moreover, in October 2019, Becton, Dickinson, and Company recently launched the BD Intevia 1mL two-step disposable auto injector. It is a robust platform device combining auto injector and pre-fillable syringe in one integrated system.

The North America Region is the Most Lucrative Region for the Self-injections

Depending upon the region, the global self-injections market is segmented into North America, Europe, Asia-Pacific, and LAMEA. The North American region dominates the global self-injections market. High prevalence of diabetes and cancer diseases are increasing demand for self-injections in this region. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Asia-Pacific is the fastest-growing region over the forecasted period owing to the rise in awareness about various chronic disorders, rapidly changing health care infrastructure in developing economies such as China and India, and well-established pharmaceutical market in Japan.

Need Assistance? Send an Enquiry@ https://www.infiniumglobalresearch.com/reports/enquiry/4853

Global Self-injections Coverage

Chapter - 1 Preface

    --  Report Description
    --  Research Methods
    --  Research Approaches

Chapter - 2 Executive Summary

    --  Self-injections Market Highlights
    --  Self-injections Market Projection
    --  Self-injections Market Regional Highlights

Chapter - 3 Global Self-injections Market Overview

    --  Introduction
    --  Market Dynamics
    --  Porter's Five Forces Analysis
    --  IGR-Growth Matrix Analysis
    --  Value Chain Analysis of Self-injections Market

Chapter - 4 Self-injections Market Macro Indicator Analysis

Chapter - 5 Global Self-injections Market by Type

    --  Wearable Injectors
    --  Needle-free Injectors
    --  Pen Injectors
    --  Auto Injectors

Chapter - 6 Global Self-injections Market by Applications

    --  Respiratory Therapy
    --  Autoimmune Diseases
    --  Orphan Diseases
    --  Hormonal Disorders

Chapter - 7 Global Self-injections Market by Usage

    --  Reusable
    --  Disposable

Chapter - 8 Global Self-injections Market by Distribution Channel

    --  Online Pharmacies
    --  Private Clinics
    --  Hospital Pharmacies

Chapter - 9 Global Self-injections Market by Region 2018-2024

    --  North America
    --  Europe
    --  Asia-Pacific
    --  RoW

Chapter - 10 Company Profiles and Competitive Landscape

    --  Wilhelm Haselmeier GmbH & Co. KG
    --  Becton, Dickinson and Company
    --  SHL Group
    --  Gerresheimer AG
    --  Owen Mumford Ltd
    --  Insulet Corporation
    --  Sensile Medical AG
    --  Ypsomed AG
    --  Consort Medical plc
    --  West Pharmaceutical Services, Inc.

Browse in-depth TOC on "Self-injections Market"

About Us

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

Contact:
Mr. Shrikant Athavale
Infinium Global Research
Office No. 103 and 104,
Suratwala Mark Plazzo,
Hinjawadi, Pune,
Maharashtra,
Pin- 411057.
USA: +1-888-500-3114
Email: info@infiniumglobalresearch.com
Research Insight: https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-self-injections-market
Visit Our Web Site: https://www.infiniumglobalresearch.com

View original content:http://www.prnewswire.com/news-releases/self-injections-market---a-common-practice-in-modern-medicine-infinium-global-research-301025303.html

SOURCE Infinium Global Research